SYRS Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.

$6.53  -0.32 (-4.67%)
As of 04/09/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/30/2016
Outstanding shares:  61,639,252
Average volume:  723,823
Market cap:   $402,504,316
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87184Q107
ISIN:        US87184Q1076
Sedol:      BYMX5N2
Valuation   (See tab for details)
PE ratio:   -4.79
PB ratio:   4.05
PS ratio:   26.67
Return on equity:   -92.81%
Net income %:   -556.76%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy